The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 21 , ISSUE 8 ( August, 2020 ) > List of Articles


Topical Curcumin and Triamcinolone Acetonide in Recurrent Minor Aphthous Ulcers: A Pilot Trial

Chandrasekar Lakshmi Krithika, SP Nehru Anand, Gayathri Ponnusami Subramani

Citation Information : Krithika CL, Anand SN, Subramani GP. Topical Curcumin and Triamcinolone Acetonide in Recurrent Minor Aphthous Ulcers: A Pilot Trial. J Contemp Dent Pract 2020; 21 (8):884-890.

DOI: 10.5005/jp-journals-10024-2901

License: CC BY-NC 4.0

Published Online: 28-12-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Aim: To evaluate the efficacy of topical curcumin and topical triamcinolone acetonide in a professional population with minor aphthous ulcers by assessing six clinical variables: site, size, pain, healing period, frequency of recurrence and number of ulcers. Materials and methods: This randomized, parallel designed pilot trial was performed on 60 symptomatic individuals with minor aphthous ulcer. Willing participants were allocated randomly into group I and group II. Participants in group I were treated with topical curcumin and group II were treated with topical triamcinolone acetonide for a period of 6 months. All participants were blinded to the drug they received. Participants were assessed on day 1, day 3, day 5, day 7, and after healing for symptomatic reduction in pain, size, healing period, frequency of recurrence, and in the number of ulcers. Statistically, independent sample t test, Chi-square test, and Log rank Kaplan–Meier survival analysis were performed. Results: Lower labial mucosa was found to be the predominant site of minor aphthous ulcer in both the groups. A gradual reduction in pain and size was noted in both the groups with statistical significance of p value <0.001. All the ulcers in both the groups healed completely without scarring within 2 weeks with statistical significance. In both the treatment groups, new ulcers occurred throughout the follow-up period of 6 months. The mean number of the ulcers are statistically not significant with p value >0.05. Conclusion: Our study showed clinically beneficial effects with topical curcumin with regard to ulcer size, pain, healing, and recurrence rate. Also topical curcumin gel was well tolerated and performed ot par with topical triamcinolone acetonide oral paste with a borderline favorable result with triamcinolone. Clinical relevance: Curcumin can be safely recommended on a long-term basis as a more appealing therapeutic agent and is a better alternative choice for aphthous ulcers in children, pregnant woman, lactating mother, and in immunocompromised individuals.

  1. Tappuni AR, Kovacevic T, Shirlaw PJ, et al. Clinical assessment of disease severity in recurrent aphthous stomatitis. J Oral Pathol Med 2013;42(8):635–641. DOI: 10.1111/jop.12059.
  2. Liang MW, Neoh CY. Oral aphthosis: management gaps and recent advances. Ann Acad Med Singapore 2012;41(10):443–470.
  3. Byahatti SM. Incidence of recurrent aphthous ulcers in a group of student population in libya: a questionnaire study. Arch CranOroFac Sci 2013;1(2):26–30.
  4. Arun Kumar M, Ananthakrishnan V, Goturu J. Correlation of ulcer size and serum cortisol in subjects with aphthous ulcers. Int J Sci Res 2013;2(11):381–382.
  5. Sharma M, Gupta R, Singh S. Correlation of psychological stress with recurrent aphthous stomatitis among dental students in an educational institution. Int J Appl Dent Sci 2017;3(4): 455–458.
  6. Nita C-W. Safety and anti inflammatory activity of curcumin: a component of turmeric (Curcuma longa) J Altern Complement Med 2003;9(1):161–168. DOI: 10.1089/107555303321223035.
  7. Shrishai D, Harish H, Ravichandra H, et al. Turmeric: nature's precious medicine. Asian J Pharm Cl in Res 2013;6(3):10–16.
  8. Lawande SA. Therapeutic applications of turmeric in dentistry: a promising future. J Pharm Biomed Sci 2013;27(27):586–591.
  9. Belenguer-Guallar I, Jiménez-Soriano Y, Claramunt-Lozano A. Treatment of recurrent aphthous stomatitis. A literature review. J Clin Exp Dent 2014;6(2):e168–e174. DOI: 10.4317/jced.51401.
  10. González-Moles MA. The use of topical corticoids in oral pathology. Med Oral Pathol Oral Cir Buccal 2010;1(15):e827–e831. DOI: 10.4317/medoral.15.e827.
  11. Greer Jr RO, Lindenmuth JE, Juarez T, et al. A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg 1993;51(3):243–248. DOI: 10.1016/S0278-2391(10)80164-8.
  12. Scully C. Clinical practice. aphthous ulceration. N Engl J Med 2006;355(2):165–172. DOI: 10.1056/NEJMcp054630.
  13. Natah SS, Konttinen YT, Enattah NS, et al. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 2004;33(3):221–234. DOI: 10.1006/ijom.2002.0446.
  14. Deshmukh RA, Bagewadi AS. Comparison of effectiveness of curcumin with triamcinolone acetonide in the gel form in treatment of minor recurrent aphthous stomatitis: a randomized clinical trial. Int J Pharm Investig 2014;4(3):138–141. DOI: 10.4103/2230-973X.138346.
  15. Pongissawaranun W, Laohapand P. Epidemiologic study on recurrent aphthous stomatitis in a thai dental patient population. Community Dent Oral Epidemiol 1991;19(1):52–53. DOI: 10.1111/j.1600-0528.1991.tb00106.x.
  16. Huling LB, Baccaglini L, Choquette L, et al. Effect of stressful life events on the onset and duration of recurrent aphthous stomatitis. J Oral Pathol Med 2012;41(2):149–152. DOI: 10.1111/j.1600-0714.2011.01102.x.
  17. Nolan A, Baillie C, Badminton J, et al. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. J Oral Pathol Med 2006;35(8):461–465. DOI: 10.1111/j.1600-0714.2006.00433.x.
  18. Malayil S, Thomas J, Rani Mol P, et al. Frequency of patients presenting with recurrent aphthous stomatitis: A pilot study. J Dent Med Sci 2014;13(1):63–66. DOI: 10.9790/0853-13186366.
  19. Abdullah J. Prevalence of recurrent aphthous ulceration experience in participants attending piramird dental speciality in Sulaimani city. J Clin Exp Dent 2013;5(2):e89–e94. DOI: 10.4317/jced.51042.
  20. Leonardo ML, Diogo MD, Arnaldo Jr FC, et al. Prevalence and risk factors for the development of RAS. Rev Cir Traumatol Buco-Maxilo-fac Camaragibe 2010;10(2):61–66.
  21. McCullough MJ, Abdel-Hafeth S, Scully C. Recurrent aphthous stomatitis revisited; clinical features, associations, and new association with infant feeding practices. J Oral Pathol Med 2007;36(10):615–620. DOI: 10.1111/j.1600-0714.2007.00589.x.
  22. Bhat S, Sujatha D. A clinical evaluation of 5% amlexanox oral paste in the treatment of minor recurrent aphthous ulcers and comparison with the placebo paste: a randomized, vehicle controlled, parallel, single centre clinical trial. Indian J Dent Res 2013;24(5):593–598. DOI: 10.4103/0970-9290.123382.
  23. Halim D, Abdul Khalik NIB, Taib H, et al. Novel material in the treatment of minor oral recurrent aphthous stomatitis. Int Med J 2013;20(3):392–394.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.